R. Judge

1.6k total citations
32 papers, 1.0k citations indexed

About

R. Judge is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, R. Judge has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 12 papers in Experimental and Cognitive Psychology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in R. Judge's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (12 papers), Treatment of Major Depression (12 papers) and Mental Health Research Topics (6 papers). R. Judge is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (12 papers), Treatment of Major Depression (12 papers) and Mental Health Research Topics (6 papers). R. Judge collaborates with scholars based in United Kingdom, United States and Denmark. R. Judge's co-authors include Y. Lecrubier, I. Hindmarch, Graham J. Emslie, G. Dunbar, A. Bakker, Jan K. Öhrström, K. Behnke, P. M. Manniche, B. Severin and Deborah Quail and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The British Journal of Psychiatry.

In The Last Decade

R. Judge

30 papers receiving 926 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Judge United Kingdom 13 452 358 324 244 97 32 1.0k
Jamie Kane United States 6 177 0.4× 144 0.4× 284 0.9× 887 3.6× 48 0.5× 13 1.2k
N. Dantchev France 12 165 0.4× 196 0.5× 143 0.4× 212 0.9× 18 0.2× 29 796
Scott Bull United States 14 126 0.3× 291 0.8× 364 1.1× 794 3.3× 27 0.3× 29 1.5k
Nicolas Despiégel France 17 188 0.4× 302 0.8× 71 0.2× 151 0.6× 33 0.3× 38 698
Glenn Catalano United States 17 74 0.2× 131 0.4× 178 0.5× 362 1.5× 72 0.7× 75 949
Christine Leong Canada 17 174 0.4× 79 0.2× 108 0.3× 211 0.9× 54 0.6× 58 852
Edmund C. Settle United States 10 113 0.3× 253 0.7× 64 0.2× 289 1.2× 38 0.4× 15 598
Sophie Billioti de Gage France 11 399 0.9× 71 0.2× 54 0.2× 452 1.9× 97 1.0× 18 1.1k
Vanessa Delgado Nunes United Kingdom 9 96 0.2× 257 0.7× 195 0.6× 164 0.7× 20 0.2× 12 934
Toshiaki Kikuchi Japan 21 243 0.5× 271 0.8× 175 0.5× 482 2.0× 8 0.1× 76 1.1k

Countries citing papers authored by R. Judge

Since Specialization
Citations

This map shows the geographic impact of R. Judge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Judge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Judge more than expected).

Fields of papers citing papers by R. Judge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Judge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Judge. The network helps show where R. Judge may publish in the future.

Co-authorship network of co-authors of R. Judge

This figure shows the co-authorship network connecting the top 25 collaborators of R. Judge. A scholar is included among the top collaborators of R. Judge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Judge. R. Judge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bramham, Jessica, Kate Bramham, R. Judge, et al.. (2024). Improving kidney care for people with severe mental health difficulties: A thematic analysis of personal and family members’ perspectives. Journal of Health Psychology. 30(5). 1044–1058. 1 indexed citations
2.
Judge, R., et al.. (2021). Spontaneous pneumomediastinum in a young man. British Journal of Hospital Medicine. 82(2). 1–2.
3.
Raisi‐Estabragh, Zahra, Jackie Cooper, R. Judge, et al.. (2020). Age, sex and disease-specific associations between resting heart rate and cardiovascular mortality in the UK BIOBANK. PLoS ONE. 15(5). e0233898–e0233898. 22 indexed citations
4.
Forlano, Roberta, Benjamin H. Mullish, Sujit Mukherjee, et al.. (2020). In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19. PLoS ONE. 15(10). e0240400–e0240400. 51 indexed citations
5.
Chang, Yaoguang, et al.. (2013). The kidney as a new target for antidiabetic drugs: SGLT2 inhibitors. Journal of Clinical Pharmacy and Therapeutics. 38(5). 350–359. 29 indexed citations
6.
Chang, Yaoguang, et al.. (2012). Vitamin D and type 2 diabetes mellitus. Journal of Clinical Pharmacy and Therapeutics. 38(2). 81–84. 11 indexed citations
7.
Judge, R., M G Parry, Deborah Quail, & Jennie G. Jacobson. (2002). Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment. International Clinical Psychopharmacology. 17(5). 217–225. 71 indexed citations
8.
Judge, R., et al.. (2000). Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors. Acta Psychiatrica Scandinavica. 101(S403). 17–25. 175 indexed citations
9.
Emslie, Graham J. & R. Judge. (2000). Tricyclic antidepressants and selective serotonin reuptake inhibitors: use during pregnancy, in children/adolescents and in the elderly. Acta Psychiatrica Scandinavica. 101(S403). 26–34. 51 indexed citations
10.
Montgomery, Stuart & R. Judge. (2000). Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatrica Scandinavica. 101(S403). 9–16. 15 indexed citations
11.
Fava, M., et al.. (2000). Fluoxetine versus sertraline and paroxetine in major depression: Long‐term changes in weight. International Journal of Gynecology & Obstetrics. 70(S3). 1 indexed citations
12.
Steiner, M., et al.. (2000). Fluoxetine improves social functioning in women with premenstrual dysphoric disorder (PMDD). International Journal of Gynecology & Obstetrics. 70(S3). 4 indexed citations
13.
Lecrubier, Y., et al.. (1997). A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Acta Psychiatrica Scandinavica. 95(2). 145–152. 113 indexed citations
14.
Lecrubier, Y., et al.. (1997). Long‐term evaluation of paroxetine, clomipramine and placebo in panic disorder. Acta Psychiatrica Scandinavica. 95(2). 153–160. 107 indexed citations
15.
Lydiard, R. Bruce, Mark H. Pollack, R. Judge, David Michelson, & R. Tamura. (1997). P.3.055 Fluoxetine in panic disorder: A placebo-controlled study. European Neuropsychopharmacology. 7. S243–S243. 3 indexed citations
16.
Judge, R., Daniel B. Burnham, Martin Steiner, et al.. (1996). Paroxetine long-term safety and efficacy in panic disorder and prevention of relapse: A double-blind study. European Psychiatry. 11. 346s–347s. 8 indexed citations
17.
Judge, R. & Martin Steiner. (1996). The long-term efficacy and safety of paroxetine in panic disorder. European Neuropsychopharmacology. 6. 207–207. 10 indexed citations
18.
Judge, R. & G. Dunbar. (1995). P-5-25 Paroxetine, clomipramine and placebo in the treatment of panic disorder. European Neuropsychopharmacology. 5(3). 361–361. 4 indexed citations
19.
Behnke, K., et al.. (1995). Paroxetine in the Treatment of Panic Disorder a Randomised, Double-Blind, Placebo-Controlled Study. The British Journal of Psychiatry. 167(3). 374–379. 195 indexed citations
20.
Judge, R., et al.. (1993). Paroxetine in the treatment of panic disorder. European Neuropsychopharmacology. 3(3). 374–375. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jamie Kane Breakdown of academic impact, for papers by N. Dantchev Breakdown of academic impact, for papers by Scott Bull Breakdown of academic impact, for papers by Nicolas Despiégel Breakdown of academic impact, for papers by Glenn Catalano Breakdown of academic impact, for papers by Christine Leong Breakdown of academic impact, for papers by Edmund C. Settle Breakdown of academic impact, for papers by Sophie Billioti de Gage Breakdown of academic impact, for papers by Vanessa Delgado Nunes Breakdown of academic impact, for papers by Toshiaki Kikuchi
Rankless by CCL
2026